Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...

Robotic biomanufacturing company Multiply Labs said it has made a significant advance toward its goal of scaling production of cell and gene therapies by using Nvidia’s open Isaac and GR00T robotics ...

The biotech automation company released artificial intelligence software controlling robotic systems in pharmaceutical and biologics production facilities.

Cell therapy manufacturing has long been constrained by manual bottlenecks - steps that are labor-intensive, variable, and difficult to scale. Robotic automation is increasingly becoming key to ...

This vision centers on anticipating future needs and pioneering breakthroughs in computing, quality of life, and sustainable resource use. Recent developments indicate that this transformation is ...

When China’s National People’s Congress convened in Beijing last week to review the draft outline of the 15th Five-Year Plan ...

Megan Levings receives funding from the Canadian Foundation for Innovation and BC Knowledge Development Fund for the ATMF Project. Robert A. Holt receives funding from the Canadian Foundation for ...

Through Bota's proprietary Biological Protocol Language, SAION AI converts experimental designs into standardized instructions that directly drive laboratory hardware, feeding real-world data back ...